Lee's Pharmaceutical Holdings Ltd
HKEX:950
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Lee's Pharmaceutical Holdings Ltd
HKEX:950
|
HK |
Multiples-Based Value
The Multiples-Based Value of one
Lee's Pharmaceutical Holdings Ltd
stock under the Base Case scenario is
2.03
HKD.
Compared to the current market price of 1.19 HKD,
Lee's Pharmaceutical Holdings Ltd
is
Undervalued by 41%.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
Competitors Multiples
Lee's Pharmaceutical Holdings Ltd Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| HK |
|
Lee's Pharmaceutical Holdings Ltd
HKEX:950
|
700.7m HKD | 0.5 | 7.2 | 4.4 | 4.4 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
871.6B USD | 13.1 | 41.4 | 28 | 29.9 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
578.1B USD | 6.1 | 21.4 | 14.9 | 18.3 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 4.1 | 19.7 | 11.6 | 13.1 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
229B GBP | 5.2 | 29.7 | 16.4 | 23.1 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
296.9B USD | 4.5 | 16 | 9.9 | 12.1 | |
| CH |
|
Novartis AG
SIX:NOVN
|
230.8B CHF | 5.1 | 20.5 | 12.7 | 16.3 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
244.4B USD | 105.4 | -83.6 | 386.8 | 970 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.6 | 11 | 8.1 | 9.5 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
154.1B USD | 2.5 | 19.9 | 7.7 | 10.2 | |
| UK |
|
GSK plc
XETRA:GS71
|
99.8B EUR | 2.7 | 15.2 | 8.2 | 10.2 |